AG
IONS icon

Advisor Group’s Ionis Pharmaceuticals IONS Stock Holding History

Advisor Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$566K Sell
9,369
-8,196
-47% -$488K ﹤0.01% 1580
2019
Q3 		$1.05M Buy
17,565
+7,025
+67% +$458K 0.01% 1108
2019
Q2 		$678K Sell
10,540
-12,660
-55% -$895K 0.01% 1397
2019
Q1 		$1.88M Buy
23,200
+13,510
+139% +$871K 0.02% 743
2018
Q4 		$524K Sell
9,690
-477
-5% -$24.3K 0.01% 1371
2018
Q3 		$524K Buy
10,167
+1,605
+19% +$75.4K 0.01% 1433
2018
Q2 		$357K Sell
8,562
-315
-4% -$14K ﹤0.01% 1568
2018
Q1 		$391K Sell
8,877
-635
-7% -$32.3K 0.01% 1490
2017
Q4 		$478K Sell
9,512
-432
-4% -$23.7K 0.01% 1356
2017
Q3 		$503K Buy
9,944
+211
+2% +$11.1K 0.01% 1211
2017
Q2 		$495K Buy
9,733
+708
+8% +$33K 0.01% 1149
2017
Q1 		$362K Sell
9,025
-645
-7% -$29K 0.01% 1263
2016
Q4 		$464K Sell
9,670
-1,728
-15% -$68.4K 0.01% 1063
2016
Q3 		$418K Sell
11,398
-474
-4% -$14.8K 0.01% 1070
2016
Q2 		$273K Buy
+11,872
New +$383K 0.01% 1242

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Advisor Group's IONS Position: Q4 2019 in Review

Advisor Group reduced its Ionis Pharmaceuticals (IONS) stake by 47% in Q4 2019, selling an estimated $488K and leaving 9,369 shares worth $566K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Advisor Group first reported a position in IONS in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.88M in Q1 2019. 390 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

  • Advisor Group held 9,369 shares of Ionis Pharmaceuticals worth $566K as of Q4 2019.
  • Advisor Group sold 8,196 Ionis Pharmaceuticals shares in Q4 2019, an estimated $488K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1580 holding.
  • Advisor Group first reported a position in Ionis Pharmaceuticals in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Ionis Pharmaceuticals position peaked at $1.88M in Q1 2019.
  • 390 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.